Evaluation of a Single Vaccination With a 4-Antigen Staphylococcus Aureus Vaccine (SA4Ag) in Healthy Adults Aged 18 to <65 Years

Completed · Phase 1

Conditions studied: Staphylococcal Infections

In brief

The purpose of this study is to evaluate the safety and immunogenicity of a single vaccination of an investigational vaccine against Staphylococcus aureus (SA4Ag) in healthy adults aged 18 to \<65 years.

Key facts

Study ID

NCT02364596

Run by

Pfizer

People needed

100

Starts

2015-01-01

Expected to finish

2015-02-01

Last updated by the study team

2015-04-03

Who can join

Age: 18 and older, up to 64. Sex: any. Healthy volunteers: accepted.

Where it is running

• Broward Research Group — Hollywood, Florida, United States
• Miami Research Associates — South Miami, Florida, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.